Timing of antitubulin therapy: does it matter?
Livingston
R B
RB
D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage* / Q000494:pharmacology*; D004336:Drug Antagonism; D004357:Drug Synergism; D006801:Humans; D017239:Paclitaxel / Q000008:administration & dosage* / Q000494:pharmacology*; D013997:Time Factors; D014407:Tumor Cells, Cultured; D014747:Vinblastine / Q000008:administration & dosage* / Q000031:analogs & derivatives* / Q000494:pharmacology*; D000077235:Vinorelbine
D000972:Antineoplastic Agents, Phytogenic; D014747:Vinblastine; D017239:Paclitaxel; D000077235:Vinorelbine